Jasper Therapeutics, Inc. - 8-K Filing
Herb Cross resigns as CFO of Jasper Therapeutics effective October 9, 2026; Jeet Mahal appointed interim principal financial officer and Rick Ruiz named interim principal accounting officer.
Tickers: $JSPR
More Regulatory news
- SusGlobal Energy Corp. - 10-Q Filing
- Ideal Power Inc. - 8-K Filing
- DIGI INTERNATIONAL INC - 8-K Filing
- ZeroStack Corp. - 8-K Filing
- Sound Point Meridian Capital, Inc. - 8-K Filing
- Boost Run Inc. - 8-K Filing
- INTERFACE INC - 8-K Filing
- Neonode Inc. - 10-Q Filing
- Virtuix Holdings Inc. - 8-K Filing
- Neonode Inc. - 8-K Filing